PROCEPT BioRobotics Corporation Peer Comparison
Metric | Value | Ranking | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $3.7 Billion | 2/16 | ITGR $4.7B |
PRCT $3.7B |
LIVN $2.6B |
CNMD $2.0B |
RXST $1.2B |
FNA $1.1B |
ESTA $1.0B |
AXGN $797.9M |
OFIX $711.2M |
SIBN $687.4M |
TMCI $628.0M |
KIDS $596.2M |
SRDX $487.5M |
NPCE $367.4M |
LUNG $275.2M |
SGHT $139.1M |
Gross Margin | 63% | 13/16 | SGHT 84% |
TMCI 80% |
SIBN 79% |
AXGN 75% |
SRDX 75% |
LUNG 74% |
FNA 74% |
KIDS 73% |
NPCE 73% |
LIVN 71% |
OFIX 69% |
ESTA 64% |
PRCT 63% |
CNMD 57% |
RXST 56% |
ITGR 16% |
Profit Margin | -36% | 13/16 | CNMD 15% |
LIVN 10% |
ITGR 5% |
NPCE 0% |
AXGN -4% |
SRDX -12% |
OFIX -14% |
RXST -14% |
KIDS -15% |
SIBN -16% |
FNA -20% |
TMCI -34% |
PRCT -36% |
ESTA -41% |
SGHT -55% |
LUNG -69% |
EBITDA margin | -32% | 12/16 | LIVN 23% |
CNMD 21% |
ITGR 8% |
SRDX 0% |
AXGN -1% |
OFIX -6% |
KIDS -10% |
FNA -14% |
SIBN -19% |
NPCE -20% |
RXST -20% |
PRCT -32% |
TMCI -34% |
SGHT -56% |
LUNG -69% |
ESTA -115% |
Quarterly Revenue | $58.4 Million | 6/16 | ITGR $746.3M |
LIVN $318.1M |
CNMD $316.7M |
OFIX $196.6M |
FNA $62.3M |
PRCT $58.4M |
KIDS $54.6M |
AXGN $48.6M |
RXST $45.4M |
TMCI $45.1M |
SIBN $40.3M |
ESTA $40.2M |
SRDX $29.9M |
NPCE $21.1M |
LUNG $20.4M |
SGHT $20.2M |
Quarterly Earnings | -$21.0 Million | 15/16 | CNMD $49.0M |
ITGR $35.4M |
LIVN $33.0M |
NPCE -$0 |
AXGN -$1.9M |
SRDX -$3.7M |
RXST -$6.3M |
SIBN -$6.6M |
KIDS -$7.9M |
SGHT -$11.1M |
FNA -$12.3M |
LUNG -$14.1M |
TMCI -$15.4M |
ESTA -$16.7M |
PRCT -$21.0M |
OFIX -$27.4M |
Quarterly Free Cash Flow | -$19.0 Million | 16/16 | ITGR $131.8M |
CNMD $47.8M |
LIVN $32.8M |
OFIX $32.1M |
AXGN $4.0M |
SGHT $549,000 |
RXST -$373,000 |
NPCE -$1.6M |
SIBN -$2.7M |
FNA -$5.8M |
ESTA -$7.0M |
LUNG -$7.7M |
SRDX -$8.2M |
KIDS -$11.3M |
TMCI -$14.7M |
PRCT -$19.0M |
Trailing 4 Quarters Revenue | $199.8 Million | 7/16 | ITGR $2.0B |
CNMD $1.3B |
LIVN $1.2B |
OFIX $784.2M |
FNA $245.0M |
TMCI $202.9M |
PRCT $199.8M |
KIDS $189.7M |
AXGN $180.9M |
SIBN $157.0M |
ESTA $153.1M |
RXST $147.2M |
SRDX $125.4M |
SGHT $79.5M |
NPCE $76.5M |
LUNG $60.0M |
Trailing 4 Quarters Earnings | -$100.1 Million | 15/16 | ITGR $746.3M |
LIVN $318.1M |
CNMD $316.7M |
OFIX $196.6M |
FNA $62.3M |
PRCT $58.4M |
KIDS $54.6M |
AXGN $48.6M |
RXST $45.4M |
TMCI $45.1M |
SIBN $40.3M |
ESTA $40.2M |
SRDX $29.9M |
NPCE $21.1M |
LUNG $20.4M |
SGHT $20.2M |
Quarterly Earnings Growth | 15% | 9/16 | LIVN 550% |
CNMD 209% |
NPCE 100% |
AXGN 55% |
RXST 49% |
ESTA 43% |
SIBN 34% |
ITGR 30% |
PRCT 15% |
SGHT 15% |
TMCI 12% |
OFIX 5% |
LUNG 5% |
FNA -48% |
KIDS -72% |
SRDX -365% |
Annual Earnings Growth | 0% | 12/16 | LIVN 737% |
CNMD 131% |
RXST 43% |
AXGN 39% |
NPCE 35% |
LUNG 32% |
OFIX 19% |
ITGR 15% |
SIBN 14% |
SGHT 12% |
ESTA 11% |
PRCT 0% |
TMCI -13% |
FNA -48% |
KIDS -115% |
SRDX -175% |
Quarterly Revenue Growth | 66% | 1/16 | PRCT 66% |
RXST 48% |
KIDS 37% |
NPCE 28% |
SIBN 19% |
AXGN 18% |
FNA 18% |
LUNG 15% |
LIVN 11% |
TMCI 11% |
OFIX 7% |
ITGR 6% |
CNMD 4% |
ESTA 4% |
SGHT 1% |
SRDX -2% |
Annual Revenue Growth | 49% | 2/16 | RXST 58% |
PRCT 49% |
TMCI 22% |
KIDS 20% |
FNA 19% |
SIBN 17% |
AXGN 16% |
NPCE 16% |
SRDX 10% |
LIVN 6% |
ITGR 6% |
OFIX 5% |
CNMD 2% |
SGHT -12% |
LUNG -13% |
ESTA -17% |
Cash On Hand | $196.8 Million | 2/16 | LIVN $346.4M |
PRCT $196.8M |
SGHT $118.6M |
LUNG $63.3M |
KIDS $51.0M |
ESTA $39.7M |
FNA $39.1M |
CNMD $38.5M |
ITGR $35.6M |
SIBN $30.2M |
SRDX $30.1M |
OFIX $30.1M |
AXGN $18.7M |
RXST $16.7M |
NPCE $15.4M |
TMCI $12.1M |
Short Term Debt | $1.8 Million | 5/16 | LIVN $22.0M |
ITGR $13.9M |
OFIX $7.0M |
AXGN $1.9M |
PRCT $1.8M |
NPCE $1.8M |
SIBN $1.2M |
SRDX $1.0M |
LUNG $762,000 |
RXST $734,000 |
CNMD $717,000 |
FNA $640,000 |
TMCI $403,000 |
KIDS $158,000 |
ESTA -$0 |
SGHT -$0 |
Long Term Debt | $51.4 Million | 10/16 | ITGR $1.2B |
CNMD $940.1M |
LIVN $604.3M |
OFIX $130.2M |
FNA $110.0M |
NPCE $71.7M |
TMCI $69.7M |
AXGN $67.0M |
LUNG $55.0M |
PRCT $51.4M |
SIBN $37.3M |
SGHT $34.2M |
SRDX $32.0M |
KIDS $24.4M |
RXST $10.6M |
ESTA $3.8M |
PE | -1.00 | 4/16 | LIVN 109.31 |
ITGR 41.65 |
CNMD 14.81 |
PRCT -1.00 |
AXGN -1.00 |
SRDX -1.00 |
OFIX -1.00 |
KIDS -1.00 |
ESTA -1.00 |
SIBN -1.00 |
LUNG -1.00 |
NPCE -1.00 |
TMCI -1.00 |
SGHT -1.00 |
RXST -1.00 |
FNA -1.00 |
PS | 18.40 | 1/16 | PRCT 18.40 |
RXST 8.16 |
ESTA 6.78 |
NPCE 4.81 |
LUNG 4.59 |
FNA 4.46 |
AXGN 4.41 |
SIBN 4.38 |
SRDX 3.89 |
KIDS 3.14 |
TMCI 3.10 |
ITGR 2.35 |
LIVN 2.09 |
SGHT 1.75 |
CNMD 1.51 |
OFIX 0.91 |
PB | 15.25 | 3/16 | NPCE 37.41 |
ESTA 31.73 |
PRCT 15.25 |
AXGN 8.03 |
FNA 7.84 |
TMCI 5.99 |
SRDX 4.36 |
RXST 4.33 |
SIBN 4.17 |
LUNG 2.93 |
ITGR 2.92 |
CNMD 2.09 |
LIVN 1.98 |
KIDS 1.61 |
SGHT 1.46 |
OFIX 1.35 |
PC | 18.69 | 11/16 | ITGR 132.95 |
RXST 71.86 |
TMCI 51.85 |
CNMD 50.71 |
AXGN 42.75 |
FNA 27.93 |
ESTA 26.14 |
NPCE 23.83 |
OFIX 23.66 |
SIBN 22.74 |
PRCT 18.69 |
SRDX 16.17 |
KIDS 11.68 |
LIVN 7.47 |
LUNG 4.35 |
SGHT 1.17 |
Liabilities to Equity | 0.55 | 11/16 | NPCE 8.80 |
ESTA 7.64 |
CNMD 1.48 |
FNA 1.17 |
TMCI 1.03 |
ITGR 0.95 |
LIVN 0.93 |
AXGN 0.93 |
LUNG 0.78 |
OFIX 0.65 |
PRCT 0.55 |
SGHT 0.51 |
SRDX 0.46 |
SIBN 0.38 |
KIDS 0.32 |
RXST 0.12 |
ROA | -0.27 | 14/16 | CNMD 6% | ITGR 4% | LIVN 1% | KIDS -6% | AXGN -8% | SRDX -9% | RXST -10% | OFIX -14% | SIBN -16% | FNA -20% | NPCE -24% | ESTA -25% | LUNG -26% | PRCT -27% | TMCI -29% | SGHT -35% |
ROE | -0.41 | 10/16 | CNMD 14% |
ITGR 7% |
LIVN 2% |
KIDS -8% |
RXST -11% |
SRDX -13% |
AXGN -15% |
OFIX -23% |
SIBN -23% |
PRCT -41% |
FNA -44% |
LUNG -46% |
SGHT -53% |
TMCI -59% |
ESTA -216% |
NPCE -230% |
Current Ratio | 2.81 | 6/16 | RXST 9.35 |
KIDS 4.13 |
SIBN 3.66 |
SRDX 3.15 |
SGHT 2.95 |
PRCT 2.81 |
OFIX 2.54 |
LUNG 2.28 |
LIVN 2.08 |
AXGN 2.07 |
ITGR 2.05 |
TMCI 1.97 |
FNA 1.86 |
CNMD 1.67 |
ESTA 1.13 |
NPCE 1.11 |
Quick Ratio | 1.48 | 4/16 | LIVN 109.31 |
ITGR 41.65 |
CNMD 14.81 |
PRCT -1.00 |
AXGN -1.00 |
SRDX -1.00 |
OFIX -1.00 |
KIDS -1.00 |
ESTA -1.00 |
SIBN -1.00 |
LUNG -1.00 |
NPCE -1.00 |
TMCI -1.00 |
SGHT -1.00 |
RXST -1.00 |
FNA -1.00 |
Long Term Debt to Equity | 0.21 | 13/16 | NPCE} 7.30 |
CNMD} 1.01 |
FNA} 0.79 |
ITGR} 0.71 |
AXGN} 0.67 |
TMCI} 0.66 |
LUNG} 0.59 |
LIVN} 0.46 |
SGHT} 0.36 |
SRDX} 0.29 |
OFIX} 0.25 |
SIBN} 0.23 |
PRCT} 0.21 |
ESTA} 0.12 |
KIDS} 0.07 |
RXST} 0.04 |
Debt to Equity | 0.21 | 13/16 | NPCE 7.48 |
CNMD 1.01 |
FNA 0.79 |
ITGR 0.72 |
AXGN 0.69 |
TMCI 0.66 |
LUNG 0.59 |
LIVN 0.48 |
SGHT 0.36 |
SRDX 0.30 |
OFIX 0.26 |
SIBN 0.23 |
PRCT 0.21 |
ESTA 0.12 |
KIDS 0.07 |
RXST 0.04 |
Burn Rate | 8.38 | 2/16 | SGHT 9.54 |
PRCT 8.38 |
SRDX 5.81 |
KIDS 5.71 |
LUNG 3.83 |
AXGN 3.73 |
SIBN 3.61 |
ITGR 2.48 |
RXST 2.41 |
ESTA 2.36 |
FNA 2.32 |
OFIX 0.88 |
TMCI 0.66 |
NPCE -1.00 |
CNMD -3.43 |
LIVN -105.16 |
Cash to Cap | 0.05 | 6/16 | SGHT 0.85 |
LUNG 0.23 |
LIVN 0.13 |
KIDS 0.09 |
SRDX 0.06 |
PRCT 0.05 |
OFIX 0.04 |
ESTA 0.04 |
SIBN 0.04 |
NPCE 0.04 |
FNA 0.04 |
AXGN 0.02 |
CNMD 0.02 |
TMCI 0.02 |
ITGR 0.01 |
RXST 0.01 |
CCR | 0.91 | 7/16 | ITGR 3.72 |
SRDX 2.24 |
KIDS 1.43 |
LIVN 1.00 |
CNMD 0.98 |
TMCI 0.96 |
PRCT 0.91 |
LUNG 0.54 |
FNA 0.47 |
ESTA 0.42 |
SIBN 0.42 |
RXST 0.06 |
SGHT -0.05 |
NPCE -1.00 |
OFIX -1.17 |
AXGN -2.18 |
EV to EBITDA | -190.87 | 15/16 | SRDX} 23351.22 |
ITGR} 101.10 |
CNMD} 43.42 |
LIVN} 39.06 |
SGHT} -4.87 |
LUNG} -18.95 |
ESTA} -21.61 |
TMCI} -45.30 |
OFIX} -66.11 |
SIBN} -91.14 |
NPCE} -100.29 |
KIDS} -102.36 |
RXST} -129.64 |
FNA} -137.84 |
PRCT} -190.87 |
AXGN} -2683.77 |
EV to Revenue | 17.68 | 1/16 | PRCT 17.68 |
RXST 8.12 |
ESTA 6.55 |
NPCE 5.57 |
FNA 4.75 |
AXGN 4.69 |
LUNG 4.46 |
SIBN 4.43 |
SRDX 3.91 |
TMCI 3.38 |
KIDS 3.00 |
ITGR 2.92 |
LIVN 2.31 |
CNMD 2.21 |
OFIX 1.04 |
SGHT 0.69 |